Marlboro

Philip Morris International (PMI), the international tobacco giant responsible for producing Marlboro cigarettes, is approaching the reaching of a £1 billion deal to acquire UK inhaler company Ventura.

Directors at the respiratory health care company have recommended to shareholders that they accept the tobacco maker’s offer.

It comes after a broad group of leading health charities, public health experts and doctors sent a letter to the board calling for them to reject the bid.

The proposed takeover now requires the approval of shareholders holding at least a 50 per cent ownership stake in the company.

Although PMI has repeatedly stated its intention to withdraw from the cigarette market, the vast majority of its revenue comes from selling cigarettes and other ‘combustible’ tobacco products.

As such, health groups have warned that the deal would significantly damage the future prospects of the healthcare company, pushing staff and researchers away.

From a fiscal perspective at least though, it seems the potential deal is working wonders for Ventura, with share values soaring more than a third since May.

Related

Ferrari unveils ‘Luce’: Its first fully electric supercar set for 2028

February 23, 2026
by Sam Vassallo

Pricing is anticipated to sit well above €500,000

Malta’s trade deficit narrows as import shifts and export rebalancing continue in 2026

February 9, 2026
by Sam Vassallo

Over the full year, Malta’s trade deficit narrowed by €444.1 million compared with 2024

Thinking of housing as part of an urban system: what Malta can learn from Singapore’s public housing

February 6, 2026
by Sam Vassallo

Five lessons we can take from the nation twice the size of Malta